These results indicated that LOXL2 activated autophagy by promoting Erk1/2 phosphorylation to increase the expression of Atg7, thereby triggering EMT and promoting TMZ tolerance in glioma cells. This evidence concerns the gene MAPK3 and central nervous system cancer.